Cargando…
Cardiac action of the first G protein biased small molecule apelin agonist
Apelin peptide analogues displaying bias towards G protein signalling pathways have beneficial cardiovascular actions compared with the native peptide in humans in vivo. Our aim was to determine whether small molecule agonists could retain G protein bias. We have identified a biased small molecule,...
Autores principales: | Read, Cai, Fitzpatrick, Christopher M., Yang, Peiran, Kuc, Rhoda E., Maguire, Janet J., Glen, Robert C., Foster, Richard E., Davenport, Anthony P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012889/ https://www.ncbi.nlm.nih.gov/pubmed/27475715 http://dx.doi.org/10.1016/j.bcp.2016.07.018 |
Ejemplares similares
-
The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis In Vitro and Induces Vasodilatation Without Desensitisation In Vivo
por: Read, Cai, et al.
Publicado: (2021) -
Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system
por: Yang, Peiran, et al.
Publicado: (2015) -
A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension
por: Yang, Peiran, et al.
Publicado: (2019) -
Design, Characterization, and First-In-Human Study of the Vascular Actions of a Novel Biased Apelin Receptor Agonist
por: Brame, Aimee L., et al.
Publicado: (2015) -
Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor
por: Nyimanu, Duuamene, et al.
Publicado: (2019)